Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder

ClinicalTrials.gov ID: NCT00854100

Public ClinicalTrials.gov record NCT00854100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder

Study identification

NCT ID
NCT00854100
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Forest Laboratories
Industry
Enrollment
231 participants

Conditions and interventions

Interventions

  • Antidepressant + cariprazine (0.1-0.3 mg/day) Drug
  • Antidepressant + cariprazine (1-2 mg/d) Drug
  • Antidepressant + placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2009
Primary completion
Dec 5, 2010
Completion
Dec 5, 2010
Last update posted
Mar 4, 2019

2009 – 2010

United States locations

U.S. sites
41
U.S. states
21
U.S. cities
38
Facility City State ZIP Site status
Forest Investigative Site 040 Phoenix Arizona 85050
Forest Investigative Site 038 Scottsdale Arizona 85254
Forest Investigative Site Arcadia California 91007
Forest Investigative Site Encino California 91316
Forest Investigative Site Garden Grove California 92845
Forest Investigative Site Irvine California 92618
Forest Investigative Site 013 Los Alamitos California 90720
Forest Investigative Site 041 National City California 91950
Forest Investigative Site Oceanside California 92056
Forest Investigative Site 025 Denver Colorado 80239
Forest Investigative Site Norwich Connecticut 06360
Forest Investigative Site Washington D.C. District of Columbia 20016
Forest Investigative Site 007 Jacksonville Florida 32216
Forest Investigative Site 012 West Palm Beach Florida 33407
Forest Investigative Site 033 Atlanta Georgia 30306
Forest Investigative Site Roswell Georgia 30076
Forest Investigative Site Overland Park Kansas 66211
Forest Investigative Site 042 Fall River Massachusetts 02721
Forest Investigative Site 034 Pittsfield Massachusetts 01267
Forest Investigative Site Omaha Nebraska 68131
Forest Investigative Site Cherry Hill New Jersey 08002
Forest Investigative Site 043 Brooklyn New York 11235
Forest Investigative Site 020 Mount Kisco New York 10549
Forest Investigative Site 039 New York New York 10003
Forest Investigative Site 029 New York New York 10021
Forest Investigative Site 001 The Bronx New York 10467
Forest Investigative Site 032 Raleigh North Carolina 27607
Forest Investigative Site Canton Ohio 44718
Forest Investigative Site Dayton Ohio 45417
Forest Investigative Site 015 Portland Oregon 97210
Forest Investigative Site 006 Media Pennsylvania 19063
Forest Investigative Site Philadelphia Pennsylvania 19104
Forest Investigative Site Philadelphia Pennsylvania 19107
Forest Investigative Site 023 Memphis Tennessee 38119
Forest Investigative Site 031 Memphis Tennessee 38119
Forest Investigative Site Nashville Tennessee 37212
Forest Investigative Site San Antonio Texas 78229
Forest Investigative Site Woodstock Vermont 05091
Forest Investigative Site Richmond Virginia 23230
Forest Investigative Site Bellevue Washington 98007
Forest Investigative Site Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00854100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 4, 2019 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00854100 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →